Smith David Ross — SEC insider filings
SEC reporting owner CIK 1650274. 25 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2020-08-10 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 9 filings — 41,191 shares, $12,020,008 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 6,107 shares @ $290.03 ($1,771,191) in CHARLES RIVER LABORATORIES INTERNATIONAL, INC., filed 2021-02-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Corporate Executive VP & CFO | 16 | — | 28 legs · 41,191 sh · $12,020,008 | 30 |
| Fortrea Holdings Inc. (FTRE) | Director | 9 | — | — | 16 |
Insider filings — Smith David Ross
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 7,075 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 15,840 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 6,598 @ $0 | EDGAR |
| 2026-06-12 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 38,817 @ $0 · Tax withholding (F): 18,244 @ $16.34 · Option exercise (M): 38,817 (derivative) @ $0 · Grant/award (A): 12,852 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 38,817 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 7,282 @ $0 · Tax withholding (F): 2,185 @ $4.78 · Option exercise (M): 7,282 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 6,354 @ $0 · Tax withholding (F): 1,907 @ $25.85 · Option exercise (M): 6,354 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 7,282 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 3,846 @ $109.34 · Option exercise (M): 3,304 @ $144.67 · Option exercise (M): 1,815 @ $179.66 · Sale (S): 3,825 @ $281.49 · Sale (S): 2,606 @ $282.56 · Sale (S): 1,289 @ $283.41 · +5 more | EDGAR |
| 2022-03-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 5,152 @ $0 | EDGAR |
| 2022-02-24 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Tax withholding (F): 341 @ $293.61 · Tax withholding (F): 374 @ $289.58 | EDGAR |
| 2022-02-01 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 12,321 @ $0 · Tax withholding (F): 5,364 @ $312.24 | EDGAR |
| 2021-08-10 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Sale (S): 600 @ $406.36 · Sale (S): 1,150 @ $407.95 | EDGAR |
| 2021-06-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 1,313 @ $0 · Grant/award (A): 4,058 (derivative) @ $337.99 | EDGAR |
| 2021-05-06 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 3,305 @ $144.67 · Sale (S): 3,305 @ $340.01 · Option exercise (M): 3,305 (derivative) @ $0 | EDGAR |
| 2021-04-26 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 3,845 @ $109.34 · Sale (S): 3,845 @ $330 · Option exercise (M): 3,845 (derivative) @ $0 | EDGAR |
| 2021-04-16 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Sale (S): 2,000 @ $320 | EDGAR |
| 2021-03-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 4,366 @ $88.05 · Sale (S): 4,366 @ $290.12 · Option exercise (M): 4,366 (derivative) @ $0 | EDGAR |
| 2021-02-25 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Tax withholding (F): 289 @ $282.98 | EDGAR |
| 2021-02-24 | 4/A | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Tax withholding (F): 157 @ $289.55 · Tax withholding (F): 242 @ $283.59 | EDGAR |
| 2021-02-23 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Sale (S): 6,107 @ $290.03 · Sale (S): 1,400 @ $291.83 · Sale (S): 1,149 @ $292.37 · Tax withholding (F): 247 @ $289.55 · Tax withholding (F): 272 @ $283.59 | EDGAR |
| 2021-02-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Gift (G): 8,656 @ $0 · Gift (G): 8,656 @ $0 · Grant/award (A): 14,234 @ $0 · Tax withholding (F): 3,795 @ $260.88 | EDGAR |
| 2021-01-05 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Sale (S): 531 @ $243.71 · Sale (S): 165 @ $244.94 · Sale (S): 264 @ $245.57 · Sale (S): 535 @ $246.76 · Sale (S): 756 @ $247.89 · Sale (S): 935 @ $248.84 · +6 more | EDGAR |
| 2020-08-10 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 3,304 @ $144.67 · Sale (S): 2,297 @ $216.42 · Sale (S): 1,007 @ $216.82 · Option exercise (M): 3,304 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1650274 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs